Novo Will Work With Anthropic AI to Speed Drug Development

This story is from 2026-09-16. It is preserved in the archive; the latest stories are on the live feed.

Novo Nordisk A/S and Anthropic PBC will work together to speed up drug development using artificial intelligence, a key goal as Novo tries to catch up in the cutthroat obesity market.

Read the full story at Bloomberg AI ↗

Timeline · 1 report

2026-09-16 13:33 · Bloomberg AI
Novo Will Work With Anthropic AI to Speed Drug Development

More stories

Anthropic, OpenAI, SpaceXAI, Google sued over call to ‘pace’ AI development — Politico Technology
Google's Gemini AI hacks three other companies during security test — Sky News Technology
Gemini Hacked Three Companies in First Known Breakout by Google’s AI — Wall Street Journal Technology
AI's role in building AI surging? Anthropic says Claude now leads 26% of its R&D — Mint AI
Hackers Used Anthropic’s Claude to Break Into OpenAI — Wall Street Journal Technology
Anthropic adds support for the AGENTS.md instructions spec to Claude Code; OpenAI contributed AGENTS.md to the Agentic AI Foundation last year (Thomas Claburn/The Register) — Techmeme
Claude, Anthropic’s AI model, is helping to develop the next version of itself — Fast Company AI
Anthropic picks consulting firm to monitor AI safety, pledges to spend $1 billion — Washington Post AI

Get the daily brief of stories like this at 6:30 every morning →